The Board of Directors has two valid mandates.
The Annual General Meeting held on 29 May 2017 authorized the Board of Directors to decide to issue and/or to convey a maximum of 100,000,000 new shares and/or the company’s own shares either against payment or for free. The authorization is valid for one year from the decision of the Annual General Meeting, i.e. until 29 May 2018.
The Extraordinary General Meeting held 14 September 2017 authorized the Board of Directors to decide to issue and/or convey a maximum of 900,000,000 new shares and/or the company’s own shares either against payment or for free. The authorization is valid no longer than five years, i.e. until 14 September 2022. The authorization did not revoke the previous authorizations and it may also be used as part of the company’s incentive schemes.
The Board of Directors may also decide on a free share issue to the Company itself, so that the number of shares to be issued to the Company may not exceed 1/10 of all the Company's shares.
The Board of Directors is authorized, within the limits of the authorization, to grant also special rights referred to in chapter 10, section 1 of the Companies Act, which carry the right to receive, against payment, new shares of the company or the company’s own shares held by the company in such a manner that the subscription price of the shares is paid in cash or by using the subscriber’s receivable to set off the subscription price (convertible loan).
The subscription price of the new shares and the consideration payable for the company’s own shares may be recorded partially or fully in the reserve for invested non-restricted equity or in the share capital to the extent and in the manner decided by the Board of Directors.
The Board of Directors decides on the other terms and conditions related to the share issues and granting of the special rights. The Board of Directors has not exercised this authorisation during the financial period.